ATAGI statement and clinical guidance on AstraZeneca COVID-19 vaccine following EMA safety review

Australian Government

19 March 2021 - This statement from the Australian Technical Advisory Group on Immunisation updates advice previous provided on 16 March. 

It follows the EMA safety review of the AstraZeneca COVID-19 vaccine.

Read ATAGI Statement

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Australia , Vaccine , Safety , COVID-19